Details for 2018719178

Up to date per 04.04.2026

Actions

Title / Product Name

KONDENSIERTE PENTACYCLISCHE DERIVATE ALS MODULATOREN DER TNF-AKTIVITÄT

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2018719178

EP Publication Number

3615534

E-Number

1429989

Language

PCT Number

EP18060489

Publication Date

04.03.2020 A

15.09.2021 B1

Registration Date

15.09.2021

AT Publication Date

15.10.2021

Application Date

24.04.2018

Registration Number

Priorities

25.04.2017

17168027

IPC

A61K 31/4188 20060101AFI20210325BHEP

Maximum Duration of Protection

24.04.2038

Owner

UCB Biopharma SRLAllée de la Recherche 601070 1070 BrusselsBE

Sanofi46 Avenue de la Grand Armée75017 ParisFR

Representative

Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT

Inventor

BROOKINGS, Daniel Christopherc/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

DE HARO GARCIA, Teresac/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

FORICHER, Yann54 rue la Boétie 75008 ParisFR

HORSLEY, Helen Traceyc/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

HUTCHINGS, Martin Clivec/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

JOHNSON, James Andrewc/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

MACCOSS, Malcolmc/o Bohicket Pharma Consulting LLC 2556 Seabrook Island Road Seabrook Island South Carolina 29455US

XUAN, Mengyangc/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

ZHU, Zhaoningc/o IPD UCB Celltech 208 Bath Road Slough Berkshire SL1 3WEGB

Information about Fees